(ZEROHEDGE) – AstraZeneca has faced unceasing criticism since the start of the COVID-19 vaccine rollout due to sloppy communications with regulators and governments that led to several halts during the testing phase (including a month-long halt to a U.S. trial following disturbing cases of deadly blood clots in the UK).
As it would happen, those blood clots – which the company dismissed back during the trials as a freak coincidence – are now at the center of an international scandal that has made all adenovirus-platform vaccines (including the J&J jab, which is still facing a halt in the U.S.) suspect. While AstraZeneca continues to deny a link, the EMA – Brussels' top drug regulator – has acknowledged a likely connection, and U.S. regulators have drawn similar conclusions about J&J.
But while the EU continues to insist that the risks of taking the AZ jab are far outweighed by its societal benefits, Brussels is still sore about production shortfalls that sabotaged the early pan-EU rollout, which led to international embarrassment and even prompted some member states, like Hungary, to turn to Russia and China.
The post EU may sue AstraZeneca over botched COVID vaccine rollout appeared first on WND.
